The CXCL13‐sICAM‐1 axis is a predictive value for clinical outcomes in inflammatory diseases.[42, 43, 44] In our transcriptomic analysis of patients with NSCLC,. This evidence concerns the gene CXCL13 and non-small cell lung carcinoma.